Cargando…

Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons

OBJECTIVE: The novel Coronavirus Disease 2019 (COVID-19) has resulted in a global health crisis since first case was identified in December 2019. As the pandemic continues to strain global public health systems, elective surgeries for thoracic cancer, such as early-stage lung cancer and esophageal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiahao, Han, Yichao, Zhang, Yajie, Dong, Dong, Cao, Yuqin, Chen, Xiang, Li, Hecheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124784/
https://www.ncbi.nlm.nih.gov/pubmed/35615657
http://dx.doi.org/10.3389/fsurg.2022.742007
_version_ 1784711799627579392
author Zhang, Jiahao
Han, Yichao
Zhang, Yajie
Dong, Dong
Cao, Yuqin
Chen, Xiang
Li, Hecheng
author_facet Zhang, Jiahao
Han, Yichao
Zhang, Yajie
Dong, Dong
Cao, Yuqin
Chen, Xiang
Li, Hecheng
author_sort Zhang, Jiahao
collection PubMed
description OBJECTIVE: The novel Coronavirus Disease 2019 (COVID-19) has resulted in a global health crisis since first case was identified in December 2019. As the pandemic continues to strain global public health systems, elective surgeries for thoracic cancer, such as early-stage lung cancer and esophageal cancer (EC), have been postponed due to a shortage of medical resources and the risk of nosocomial transmission. This review is aimed to discuss the influence of COVID-19 on thoracic surgical practice, prevention of nosocomial transmission during the pandemic, and propose modifications to the standard practices in the surgical management of different thoracic cancer. METHODS: A literature search of PubMed, Medline, and Google Scholar was performed for articles focusing on COVID-19, early-stage lung cancer, and EC prior to 1 July 2021. The evidence from articles was combined with our data and experience. RESULTS: We review the challenges in the management of different thoracic cancer from the perspectives of thoracic surgeons and propose rational strategies for the diagnosis and treatment of early-stage lung cancer and EC during the COVID-19 pandemic. CONCLUSIONS: During the COVID-19 pandemic, the optimization of hospital systems and medical resources is to fight against COVID-19. Indolent early lung cancers, such as pure ground-glass nodules/opacities (GGOs), can be postponed with a lower risk of progression, while selective surgeries of more biologically aggressive tumors should be prioritized. As for EC, we recommend immediate or prioritized surgeries for patients with stage Ib or more advanced stage and patients after neoadjuvant therapy. Routine COVID-19 screening should be performed preoperatively before thoracic surgeries. Prevention of nosocomial transmission by providing appropriate personal protective equipment (PPE), such as N-95 respirator masks with eye protection to healthcare workers, is necessary.
format Online
Article
Text
id pubmed-9124784
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91247842022-05-24 Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons Zhang, Jiahao Han, Yichao Zhang, Yajie Dong, Dong Cao, Yuqin Chen, Xiang Li, Hecheng Front Surg Surgery OBJECTIVE: The novel Coronavirus Disease 2019 (COVID-19) has resulted in a global health crisis since first case was identified in December 2019. As the pandemic continues to strain global public health systems, elective surgeries for thoracic cancer, such as early-stage lung cancer and esophageal cancer (EC), have been postponed due to a shortage of medical resources and the risk of nosocomial transmission. This review is aimed to discuss the influence of COVID-19 on thoracic surgical practice, prevention of nosocomial transmission during the pandemic, and propose modifications to the standard practices in the surgical management of different thoracic cancer. METHODS: A literature search of PubMed, Medline, and Google Scholar was performed for articles focusing on COVID-19, early-stage lung cancer, and EC prior to 1 July 2021. The evidence from articles was combined with our data and experience. RESULTS: We review the challenges in the management of different thoracic cancer from the perspectives of thoracic surgeons and propose rational strategies for the diagnosis and treatment of early-stage lung cancer and EC during the COVID-19 pandemic. CONCLUSIONS: During the COVID-19 pandemic, the optimization of hospital systems and medical resources is to fight against COVID-19. Indolent early lung cancers, such as pure ground-glass nodules/opacities (GGOs), can be postponed with a lower risk of progression, while selective surgeries of more biologically aggressive tumors should be prioritized. As for EC, we recommend immediate or prioritized surgeries for patients with stage Ib or more advanced stage and patients after neoadjuvant therapy. Routine COVID-19 screening should be performed preoperatively before thoracic surgeries. Prevention of nosocomial transmission by providing appropriate personal protective equipment (PPE), such as N-95 respirator masks with eye protection to healthcare workers, is necessary. Frontiers Media S.A. 2022-05-09 /pmc/articles/PMC9124784/ /pubmed/35615657 http://dx.doi.org/10.3389/fsurg.2022.742007 Text en Copyright © 2022 Zhang, Han, Zhang, Dong, Cao, Chen and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Zhang, Jiahao
Han, Yichao
Zhang, Yajie
Dong, Dong
Cao, Yuqin
Chen, Xiang
Li, Hecheng
Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons
title Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons
title_full Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons
title_fullStr Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons
title_full_unstemmed Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons
title_short Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons
title_sort considerations for the surgical management of thoracic cancers during the covid-19 pandemic: rational strategies for thoracic surgeons
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124784/
https://www.ncbi.nlm.nih.gov/pubmed/35615657
http://dx.doi.org/10.3389/fsurg.2022.742007
work_keys_str_mv AT zhangjiahao considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons
AT hanyichao considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons
AT zhangyajie considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons
AT dongdong considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons
AT caoyuqin considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons
AT chenxiang considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons
AT lihecheng considerationsforthesurgicalmanagementofthoraciccancersduringthecovid19pandemicrationalstrategiesforthoracicsurgeons